Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Pandion Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2016 · IPO 2020 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$1.85B
Market cap · 2026
Revenue
$6.6M
Latest reported FY

Investors

8 investors on Pandion Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 3 investors entered at this stage

Patent intelligence

$7M patent portfolio · 18 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value
$7M
0.39% of market cap · 3.6× smaller than top peer Kymera Therapeutics ($26M)
18 active patent families
Where Pandion Therapeutics innovates BiochemistryMolecular biologyImmunologic ToleranceImmune privilegeLocal immunity
Above peer median on Strategic · Below peer median on Technology

Quality vs same-sector peers

Pandion Therapeutics on the five Patsnap quality dimensions

Pandion Therapeutics in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Pandion Therapeutics concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Pandion Therapeutics and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Pandion Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.